Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial

Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the unchanged 403 error page.
    Difference
    1%
    Check dated 2026-10-24T13:41:56.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:35:32.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T14:43:36.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error instead of the study record content, making the page inaccessible and preventing access to the trial details.
    Difference
    18%
    Check dated 2026-09-19T22:06:29.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.6.5 to v3.6.6, signaling a new version of the record. This reflects an update to the page without altering its substantive details.
    Difference
    0.1%
    Check dated 2026-08-29T22:04:51.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The revision tag changed from v3.6.4 to v3.6.5, indicating an internal update to the page template. This does not alter visible study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T18:12:10.000Z thumbnail image

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.